Process for analysis using a lipid membrane

Claim 2

A process of quantitatively or semi-quantitatively determining the concentration of a selected chemical species in an aqueous electrolytic solution, said process comprising (a) forming an electrochemical cell from (1) a lipid membrane deposited onto an ion conductive support and modified by incorporation of a complexing agent for selectively interacting with the chemical species to increase transmembrane ion movement, and (2) said aqueous electrolytic solution; (b) applying electrical potential difference across the modified membrane whereby said chemical species interacts with the membrane-incorporated complexing agent to produce an analytical signal based upon said transmembrane ion movements; (c) measuring said analytical signal; and (d) determining said chemical species concentration from the measured analytical signal.

Claim 3

The process of claim 1, wherein transmembrane ion current is measured.

Claim 4

The process of claim 1, wherein said chemical species is an organic compound.

Claim 5

The process of claim 1, wherein said chemical species is an inorganic ion.

Claim 6

The process of claim 1, wherein said ion conductive support is a stable gel substrate.

Claim 7

The process of claim 1, wherein said ion conductive support is a hydrogel.

Claim 8

The process of claim 6, wherein said hydrogel is physically stabilized on an electrochemical reference electrode.

Claim 9

The process of claim 1, wherein said lipid membrane is a bilayer lipid membrane.

Claim 10

The process of claim 1, wherein said lipid membrane is a monolayer lipid membrane.

Claim 11

A process of quantitatively or semi-quantitatively determining the concentration of a selected organic chemical species in an aqueous electrolytic solution, said process comprising forming a modified lipid membrane comprising (a) a receptor for selectively interacting with the organic chemical species to control transmembrane ion movement, said receptor being located in the membrane surface volume, and (b)(1) a modifying membrane structural agent and/or (2) polar groups in the hydrophobic chains of the membrane-forming lipids, for providing an ion energy barrier of appropriate magnitude by modification of molecular packing density and electrostatic potential of the lipid membrane, so as to increase the lipid membrane sensitivity and to make the effects of the organic chemical species-receptor interaction on the ion conductance as marked as possible; forming an electrochemical cell from the modified membrane and said aqueous electrolytic solution; applying electrical potential difference across said modified membrane whereby said organic chemical species interacts with the membrane-incorporated receptor to produce an analytical signal based upon said transmembrane ion movement; measuring said analytical signal; and determining said organic chemical species concentration from the measured analytical signal.

Claim 12

A process of quantitatively or semi-quantitatively determining the concentration of a selected organic chemical species in an aqueous electrolytic solution, said process comprising forming a modified lipid membrane comprising (a) a receptor for selectively interacting with the organic chemical species to control transmembrane ion movement, said receptor being located in the membrane surface volume, and (b)(1) a modifying membrane structural agent and/or (2) polar groups in the hydrophobic chains of the membrane-forming lipids, for providing an ion energy barrier of appropriate magnitude by modification of molecular packing density and electrostatic potential of the lipid membrane, so as to increase the lipid membrane sensitivity and to make the effects of the organic chemical species-receptor interaction on the ion conductance as marked as possible; forming an electrochemical cell from the modified membrane and said aqueous electrolytic solution; applying electrical potential difference across said modified membrane whereby said organic chemical species interacts with the membrane-incorporated receptor to produce an analytical signal based upon said transmembrane ion movement; measuring said analytical signal; and determining said organic chemical species concentration from the measured analytical signal.

Claim 13

The process of claim 10, wherein transmembrane ion current is measured.

Claim 14

The process of claim 10, wherein said membrane-forming lipids include phospholipids.

Claim 15

The process of claim 10, wherein said membrane-forming lipids have acyl chains of length C14-C24 on the lipid head groups.

Claim 16

The process of claim 10, wherein said membrane-forming lipids include phosphatidyl choline.

Claim 17

The process of claim 10, wherein said modifying membrane structural agent is a steroid.

Claim 18

The process of claim 10, wherein said polar groups are introduced by chemical modification of carbon-carbon unsaturation in said hydrophobic chains.

Claim 19

The process of claim 10, wherein said receptor is chemically bound in the membrane.

Claim 20

The process of claim 10, wherein said receptor is a natural product.

Claim 21

The process of claim 10, wherein said transmembrane ion movement is by a diffusion mechanism.

Claim 22

The process of claim 10, wherein said organic chemical species is an antigen, and said receptor is an antibody.

Claim 23

The process of claim 10, wherein said organic chemical species is a hormone, and said receptor is a hormone receptor.

Claim 24

The process of claim 10, wherein said organic chemical species is an enzyme, and said receptor is a substrate therefor.

Claim 25

The process of claim 10, wherein said organic chemical species is an enzyme, and said receptor is an inhibitor therefor.

Claim 26

The process of claim 23, wherein said enzyme is trypsin.

Claim 27

The process of claim 10, wherein said organic chemical species is a polysaccharide, and said receptor is a glycoreceptor.

Claim 28

The process of claim 25, wherein said glycoreceptor is concanavalin A.

Claim 29

The process of claim 26, wherein said analytical signal is in the form of step rises in current.

Claim 30

The process of claim 26, wherein said analytical signal is in the form of continuous current changes.

Claim 31

The process of claim 25, wherein the polysaccharide and glycoreceptor interact in the presence of an antibiotic providing a complexed ion form for transmembrane movement.

Claim 32

The process of claim 10, wherein said lipid membrane is a bilayer lipid membrane.

Claim 33

The process of claim 10, wherein said lipid membrane is a monolayer lipid membrane.